AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to Splenectomy

Clinical trial NCT00102336 · COMPLETED

Trial details

NCT number: NCT00102336
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Thrombocytopenia Idiopathic Thrombocytopenic Purpura

Start date: 2005-04-07
Primary completion: 2006-12-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.